EDP-305, a novel and highly potent farnesoid X receptor agonist, improves liver steatosis, ballooning and non-alcoholic fatty liver disease (NAFLD) activity score (NAS) in a diet-induced murine model of non-alcoholic steatohepatitis

被引：1
|
作者：
Jiang, L. -J. [1 ]
Chau, M. [1 ]
Li, Y. [1 ]
Briand, F. [2 ]
Sulpice, T. [2 ]
Or, Y. S. [1 ]
机构：
[1] Enanta Pharmaceut Inc, Watertown, MA USA
[2] Physiogenex, Labege, France
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31237-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-363
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [31] Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Duseja, Ajay Kumar
    De, Arka
    Mehta, Manu
    Singh, Priya
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1090 - S1090
  • [32] Efficacy and safety of the non-steroidal farnesoid X receptor agonist PX-104 in patients with non-alcoholic fatty liver disease (NAFLD)
    Traussnigg, Stefan
    Kienbacher, Christian
    Halilbasic, Emina
    Rechling, Christian
    Hofer, Harald
    Steindl-Munda, Petra E.
    Gouya, Ghazaleh
    Wolzt, Michael
    Hornberger, Martin
    Birkel, Manfred
    Kremoser, Claus
    Trauner, Michael H.
    HEPATOLOGY, 2016, 64 : 536A - 537A
  • [33] Effects of Farnesoid X Receptor (FXR) Agonist on Expression of Genes That Regulate Fatty Acid Metabolism in Hepatocyte Model of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Mehta, Rohini
    Koenig, Aaron B.
    Younoszai, Zahra
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2015, 148 (04) : S1056 - S1056
  • [34] Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion
    Maciejewska, Dominika
    Lukomska, Agnieszka
    Dec, Karolina
    Skonieczna-Zydecka, Karolina
    Gutowska, Izabela
    Skorka-Majewicz, Marta
    Styburski, Daniel
    Misiakiewicz-Has, Kamila
    Pilutin, Anna
    Palma, Joanna
    Sieletycka, Katarzyna
    Marlicz, Wojciech
    Stachowska, Ewa
    DIAGNOSTICS, 2019, 9 (04)
  • [35] Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor
    Dong Renchan
    Yang, Xiaobo
    Wang, Changyuan
    Liu, Kexin
    Liu, Zhihao
    Ma, Xiaodong
    Sun, Huijun
    Huo, Xiaokui
    Fu, Ting
    Meng, Qiang
    PHYTOMEDICINE, 2019, 53 : 134 - 142
  • [36] A novel mouse model for the study of pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Degrassi, Cristina
    Tiribelli, Claudio
    Gazzin, Silvia
    HEPATOLOGY, 2015, 62 : 1231A - 1231A
  • [37] IRW improves diet-induced non-alcoholic fatty liver disease by reducing steatosis associated with increased capacity for oxidative phosphorylation
    Zani, Stepheny C. de Campos
    Berg, Emily
    Jiang, Xu
    Knox, Alexandra
    Ackroyd, Evan
    Getachew, Aaron
    Wu, Jianping
    Chan, Catherine B.
    JOURNAL OF FUNCTIONAL FOODS, 2024, 112
  • [38] Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
    Zheng, Shuqin
    Hoos, Lizbeth
    Cook, John
    Tetzloff, Glen
    Davis, Harry, Jr.
    van Heek, Margaret
    Hwa, Joyce J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (01) : 118 - 124
  • [39] Aminotransferse Levels are not Predictive of Histologic Activity or Stage in Morbidly Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Birerdinc, Aybike
    Lei, Wang
    Ozcan, Kenan
    Nguyenngo, Cartherine
    Estep, Michael
    Afendy, Arian
    Baranova, Ancha
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S116 - S117
  • [40] Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease
    McGettigan, Brett M.
    McMahan, Rachel H.
    Luo, Yuhuan
    Wang, Xiaoxin X.
    Orlicky, David J.
    Porsche, Cara
    Levi, Moshe
    Rosen, Hugo R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 23058 - 23067
12345